A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users

Trial Profile

A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine
  • Indications Opioid abuse
  • Focus Therapeutic Use
  • Acronyms INDUCTION
  • Sponsors Essex Italia; Integrated Therapeutics Group; Merck Sharp & Dohme; Schering-Plough Research Institute
  • Most Recent Events

    • 28 Jul 2014 New trial record
    • 27 Jan 2010
    • 04 May 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top